DELFINI LISA (Chief Financial Officer) sold 7.5% of their position (4.35K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $11.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/24/2024ACC: 0000950170-24-064598
Officer· Chief Financial Officer
Since Aug 2021
-4.35K
Net shares
Net seller
$11.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.04K acquired · 20.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.04K
Price / share
$0.51
Trade value
$8.20K
% of position
38.6%
5/22/2024
41.59K→57.63K
Common Stock
Direct
Shares
−4.35K
Price / share
$2.64
Trade value
$11.48K
% of position
7.5%
5/22/2024
57.63K→53.28K
Total
Net shares
+11.69K
Net value
-$3.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2024 | M · Option Exercise | +16.04K | $0.51 | $8.20K | 38.6% | 41.59K | 57.63K |
| Common Stock Direct | 5/22/2024 | S · Sale | −4.35K | $2.64 | $11.48K | 7.5% | 57.63K | 53.28K |
| Total | +11.69K | -$3.29K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
16.04K shares
Shares
−16.04K
Strike price
0.511
Held after
48.13K
Exercisable
—
5/22/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock16.04K shares | 5/22/2024 | M · Option Exercise | −16.04K | 0.511 | — | 48.13K |